Five current and former AstraZeneca employees have been detained in China as part of an investigation into alleged illegal activities in the pharmaceutical sector. The investigation focuses on potential breaches of data privacy laws and the importation of unlicensed cancer medications, highlighting China’s crackdown on unethical practices within the healthcare industry.